1 year, 9 months ago

The One-Shot Drug That Keeps on Dosing

On average, patients with chronic illnesses follow their prescribed treatments about 50 percent of the time. And sometimes we’re missing out on a lot.” For example, the injectable drug bevacizumab can be used to treat macular degeneration, a leading cause of blindness. “And I don’t blame them at all—that’s terrible.” McHugh’s lab is in the drug delivery business. “We’re trying to engineer these delivery systems to work in the real world, as opposed to in this idealized version of the world,” McHugh says. “Having long-acting delivery strategies is a great unmet need,” says SriniVas Sadda, an ophthalmologist with UCLA and the Doheny Eye Institute who was not involved in the study.

Wired
Drug Mchugh

Discover Related